Page last updated: 2024-08-20

yohimbine and sq-11725

yohimbine has been researched along with sq-11725 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Berlan, M; Galitzky, J; Montastruc, P; Tran, MA1
Bagheri, H; Berlan, M; Chale, JJ; Guyen, LN; Montastruc, JL; Tran, MA1
Brabant, G; Drube, J; Helfritz, F; Nave, H; Pabst, R; von Hörsten, S1
Härle, P; Janele, D; Pongratz, G; Schnellinger, G; Schölmerich, J; Straub, RH1

Other Studies

6 other study(ies) available for yohimbine and sq-11725

ArticleYear
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
    Journal of medicinal chemistry, 2004, Mar-25, Volume: 47, Issue:7

    Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Anorectic effect of alpha 2-antagonists in dog: effect of acute and chronic treatment.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 39, Issue:2

    Topics: Adrenergic alpha-Antagonists; Animals; Appetite Depressants; Blood Glucose; Blood Platelets; Body Weight; Catecholamines; Cell Membrane; Dioxanes; Dogs; Fatty Acids, Nonesterified; Feeding Behavior; Idazoxan; Imidazoles; Insulin; Male; Nadolol; Yohimbine

1991
Evidence for activation of both adrenergic and cholinergic nervous pathways by yohimbine, an alpha 2-adrenoceptor antagonist.
    Fundamental & clinical pharmacology, 1995, Volume: 9, Issue:3

    Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atropine; Autonomic Pathways; Dogs; Female; Insulin; Lipids; Male; Muscarinic Antagonists; Nadolol; Norepinephrine; Parasympathetic Nervous System; Salivation; Sympathetic Nervous System; Yohimbine

1995
Leukocyte mobilization induced by hypervolemia is due to a combined alpha- and beta-adrenoceptor activation.
    Comparative medicine, 2000, Volume: 50, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Leukocyte Count; Leukocytes; Male; Nadolol; Norepinephrine; Rats; Rats, Inbred Lew; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Sodium Chloride; Specific Pathogen-Free Organisms; Stress, Physiological; Yohimbine

2000
Norepinephrine in mice inhibits secretion of splenic IL-6 during the dark period but stimulates its secretion in the light period--possible role of the corticosterone tone.
    Journal of neuroimmunology, 2005, Volume: 158, Issue:1-2

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Corticosterone; Dose-Response Relationship, Drug; Electric Stimulation; Female; Hormone Antagonists; In Vitro Techniques; Interleukin-6; Mice; Mice, Inbred Strains; Mifepristone; Nadolol; Norepinephrine; Perfusion; Phentolamine; Photoperiod; Spleen; Statistics, Nonparametric; Time Factors; Yohimbine

2005